Discover and read the best of Twitter Threads about #YesToCovid19Vaccine
Most recents (5)
PRESS STATEMENT:
Nigeria is continuing in the process of administering roughly 4 million doses of the Oxford/AstraZeneca vaccine, beginning with our frontline health workers and vulnerable individuals. There has been no change to current plans or supply.
Nigeria is continuing in the process of administering roughly 4 million doses of the Oxford/AstraZeneca vaccine, beginning with our frontline health workers and vulnerable individuals. There has been no change to current plans or supply.
A huge number of countries around the world are administering the Oxford/AstraZeneca vaccine, including much of Europe, and United Kingdom which has administered the most doses of AstraZeneca globally.
The World Health Organization, British and European health regulators all continue to advocate for the use of AstraZeneca.
Press Statement on concerns about the safety of the Oxford/AstraZeneca Vaccine.
We are aware of precautionary concerns that have been raised regarding one specific batch of the AstraZeneca vaccine, namely ABV5300.
We are aware of precautionary concerns that have been raised regarding one specific batch of the AstraZeneca vaccine, namely ABV5300.
We understand that investigations are being conducted to determine if the batch is in any way linked to an observed side effect.
While we await the outcome of the investigations, it is important to clearly state that Nigeria did not receive any doses from the batch of vaccines which is at issue.
We have answers to some questions you may have around e-REGISTRATION for #COVID19 Vaccination.
#YesToCOVID19Vaccine
#YesToCOVID19Vaccine
To register for the #COVID19Vaccine 👇👇👇
How to register? Easy! Look below 👇
How do I register for #COVID19 vaccination?
Nigeria getting about 3,924,000 doses of the Oxford/AstraZeneca COVID-19 vaccine in this first batch under the COVAX Facility. Will arrive around noon today. #YesToCovid19Vaccine
Vaccine Don Land. Nnamdi Azikiwe International Airport, Abuja.
